Next Article in Journal
Next Article in Special Issue
Previous Article in Journal
Previous Article in Special Issue
Nutrients 2012, 4(12), 1851-1867; doi:10.3390/nu4121851
Article

Dose and Latency Effects of Leucine Supplementation in Modulating Glucose Homeostasis: Opposite Effects in Healthy and Glucocorticoid-Induced Insulin-Resistance States

1,2,3,* , 2
, 2
, 1
, 1
, Jr. 4
, 3
, 5
, 1
, 2
, 3
, 2
, 6
 and Jr. 1
Received: 28 September 2012; in revised form: 1 November 2012 / Accepted: 14 November 2012 / Published: 27 November 2012
View Full-Text   |   Download PDF [442 KB, updated 28 November 2012; original version uploaded 27 November 2012]
Abstract: Dexamethasone (DEXA) is a potent immunosupressant and anti-inflammatory agent whose main side effects are muscle atrophy and insulin resistance in skeletal muscles. In this context, leucine supplementation may represent a way to limit the DEXA side effects. In this study, we have investigated the effects of a low and a high dose of leucine supplementation (via a bolus) on glucose homeostasis, muscle mass and muscle strength in energy-restricted and DEXA-treated rats. Since the leucine response may also be linked to the administration of this amino acid, we performed a second set of experiments with leucine given in bolus (via gavage) versus leucine given via drinking water. Leucine supplementation was found to produce positive effects (e.g., reduced insulin levels) only when administrated in low dosage, both via the bolus or via drinking water. However, under DEXA treatment, leucine administration was found to significantly influence this response, since leucine supplementation via drinking water clearly induced a diabetic state, whereas the same effect was not observed when supplied via the gavage.
Keywords: leucine supplementation; glucose homeostasis; skeletal muscle mass leucine supplementation; glucose homeostasis; skeletal muscle mass
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Zanchi, N.E.; Guimarães-Ferreira, L.; de Siqueira-Filho, M.A.; Felitti, V.; Nicastro, H.; Bueno, C., Jr.; Lira, F.S.; Naimo, M.A.; Campos-Ferraz, P.; Nunes, M.T.; Seelaender, M.; de Oliveira Carvalho, C.R.; Blachier, F.; Lancha, A.H., Jr. Dose and Latency Effects of Leucine Supplementation in Modulating Glucose Homeostasis: Opposite Effects in Healthy and Glucocorticoid-Induced Insulin-Resistance States. Nutrients 2012, 4, 1851-1867.

AMA Style

Zanchi NE, Guimarães-Ferreira L, de Siqueira-Filho MA, Felitti V, Nicastro H, Bueno C, Jr, Lira FS, Naimo MA, Campos-Ferraz P, Nunes MT, Seelaender M, de Oliveira Carvalho CR, Blachier F, Lancha AH, Jr. Dose and Latency Effects of Leucine Supplementation in Modulating Glucose Homeostasis: Opposite Effects in Healthy and Glucocorticoid-Induced Insulin-Resistance States. Nutrients. 2012; 4(12):1851-1867.

Chicago/Turabian Style

Zanchi, Nelo E.; Guimarães-Ferreira, Lucas; de Siqueira-Filho, Mário A.; Felitti, Vitor; Nicastro, Humberto; Bueno, Carlos, Jr.; Lira, Fábio S.; Naimo, Marshall A.; Campos-Ferraz, Patrícia; Nunes, Maria T.; Seelaender, Marília; de Oliveira Carvalho, Carla R.; Blachier, François; Lancha, Antonio H., Jr. 2012. "Dose and Latency Effects of Leucine Supplementation in Modulating Glucose Homeostasis: Opposite Effects in Healthy and Glucocorticoid-Induced Insulin-Resistance States." Nutrients 4, no. 12: 1851-1867.


Nutrients EISSN 2072-6643 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert